Adaptive Trial Design Under the New FDA Framework: Integrating ICH E20, Bayesian Methods, and Trial Innovation
Date: July 22, 2026
Duration: 60 Minutes
Time: 12 PM EST
Adaptive clinical trials are transforming the future of drug, biologic, and medical device development. Once considered innovative alternatives to traditional trial designs, adaptive methodologies are now increasingly recognized by regulators as powerful tools for improving trial efficiency, optimizing resource utilization, and accelerating development timelines without compromising scientific rigor.
Recent regulatory developments, including the FDA’s support for modern statistical methodologies and the introduction of the ICH E20 guideline on Adaptive Clinical Trials, have created new opportunities—and new expectations—for sponsors seeking regulatory approval. At the same time, advances in Bayesian statistics, platform trials, master protocols, real-time data monitoring, and AI-enabled analytics are reshaping how clinical trials are designed, conducted, and evaluated.
As regulatory expectations evolve, sponsors, CROs, biostatisticians, and clinical development professionals must understand how to effectively implement adaptive designs while maintaining trial integrity, controlling operational bias, and meeting FDA requirements.
Join FDAMap’s expert-led webinar to gain practical insights into the latest regulatory trends, scientific considerations, and operational best practices that can help you successfully design, execute, and obtain regulatory acceptance for adaptive clinical trials in today’s rapidly changing development landscape.
Why Should You Attend?
The clinical development landscape is changing rapidly. Regulatory agencies are increasingly encouraging innovative trial designs that improve efficiency while maintaining patient safety and scientific integrity. However, adaptive trials require careful planning, robust statistical justification, and proactive regulatory engagement.
This webinar will help you:
- Understand the latest FDA and ICH expectations for adaptive clinical trials
- Learn how adaptive methodologies can accelerate development timelines and reduce unnecessary costs
- Gain practical insights into Bayesian methods, platform trials, and modern trial oversight
- Identify common regulatory and operational challenges before they impact your program
- Improve the likelihood of regulatory acceptance through strategic trial design and execution
- Stay ahead of emerging trends that may influence future clinical development programs
Whether you are planning your first adaptive study or looking to enhance an existing development strategy, this webinar will provide actionable knowledge that can be immediately applied to your organization.
Topics to Be Covered
- The Evolving Regulatory Landscape
- Understanding Adaptive Trial Designs
- Bayesian Methods and Modern Statistical Innovation
- Platform Trials and Master Protocols
- Maintaining Trial Integrity
- Real-Time Monitoring and Emerging Technologies
- Regulatory Submission Strategies
- Case Studies and Lessons Learned
Who Will Benefit?
This webinar is designed for professionals involved in clinical development, regulatory strategy, trial operations, and biostatistics, including:
- Pharmaceutical and Biotechnology Executives
- Clinical Development Leaders
- Clinical Operations Professionals
- Regulatory Affairs Professionals
- Biostatisticians and Statistical Programmers
- Clinical Project Managers
- Medical Directors
- Clinical Research Scientists
- Translational Medicine Professionals
- CRO Executives and Managers
- Clinical Trial Consultants
- Quality Assurance and Compliance Professionals
- Medical Device and Combination Product Developers
- Investors and Strategic Decision Makers Evaluating Clinical Development Programs
Speaker: Mukesh Kumar
PhD, RAC | CEO, FDAMap
For more info, fill the box below. We will contact you within 24 hrs.
Webinar Fee
Prices are in US Dollars.
The registration fee includes: The live webinar & all related course materials.
Terms & Conditions to register for the Webinar
Your Registration for the workshop is subject to following terms and conditions. If you need any clarification before registering for this webinar please email us at info@fdamap.com
Payment
We accept credit card, debit card, and PayPal.
Cancellations & Substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 5 business days prior to the start date of the event will receive a refund — less a $30 administration fee. No cancellations will be accepted — nor refunds issued — within 5 business days before the start date of the event. You may however, choose to substitute the webinar for which you are registered with some other webinar in the future.
On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($30) will be transferred to any future FDA Map event and a credit note will be issued. No-shows will be charged the full amount.
Webinar material will be uploaded on the website 24 hours before the scheduled date of the webinar. In case it is not available on the website due to some technical issues, we will email the material a few hours before the start of the webinar.
In the event FDA Map cancels the webinar, FDA Map will issue a full refund to all the registrants for that webinar. Some topics and speakers may be subject to change without notice.
